Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yoko Omura‐Ohata
Observed names:
Omura-Ohata, Yoko,
Oohata Yoko,
YOKO OMURA-OHATA,
Yoko Omura-Ohata
Institutions:
National Cerebral and Cardiovascular Center,
National Cerebral and Cardiovascular Center Hospital
Observed institutions:
Tohoku University,
Tohoku University Hospital,
National Cerebral and Cardiovascular Center,
National Cerebral and Cardiovascular Center Hospital
ORCID:
0009-0008-0617-7444
Observed ORCID:
0009-0008-0617-7444
OpenAlex ID:
A5031772014
Efficacy of visceral fat estimation by dual bioelectrical impedance analysis in detecting cardiovascular risk factors in patients with type 2 diabetes
2019
·
Yoko Omura-Ohata
, Cheol Son
, et al.
·
Cardiovascular Diabetology
·
81
PDF
DAPagliflozin for the attenuation of albuminuria in Patients with hEaRt failure and type 2 diabetes (DAPPER study): a multicentre, randomised, open-label, parallel-group, standard treatment-controlled trial
2023
·
Fumiki Yoshihara
, Miki Imazu
, et al.
·
EClinicalMedicine
·
12
PDF
The effect of continuous glucose monitoring-guided glycemic control on progression of coronary atherosclerosis in type 2 diabetic patients with coronary artery disease: The OPTIMAL randomized clinical trial
2023
·
Yu Kataoka
, Satoshi Kitahara
, et al.
·
Journal of Diabetes and its Complications
·
10
Glucagon-like Peptide-1 analogues and delipidation of coronary atheroma in statin-treated type 2 diabetic patients with coronary artery disease: The prespecified sub-analysis of the OPTIMAL randomized clinical trial
2024
·
Yu Kataoka
, Satoshi Kitahara
, et al.
·
Atherosclerosis Plus
·
7
Diabetic Microvascular Complications Predicts Non-Heart Failure with Reduced Ejection Fraction in Type 2 Diabetes
2023
·
Mayu Tochiya
, Hisashi Makino
, et al.
·
ESC Heart Failure
·
5
PDF
Circulating apolipoprotein B levels in statin-treated type 2 diabetic patients with coronary artery disease: Implications for coronary atheroma progression and instability
2025
·
Sayaka Funabashi
, Yu Kataoka
, et al.
·
Journal of clinical lipidology
·
3
PDF
Effect of Luseogliflozin on Myocardial Flow Reserve in Patients with Type 2 Diabetes Mellitus (LUCENT-J Study)
2024
·
Tamiko Tamanaha
, Hisashi Makino
, et al.
·
Diabetes Therapy
·
3
PDF
Effect of empagliflozin on urinary albumin excretion and hypoxic biomarkers in early diabetic kidney disease: A randomised double‐blind, placebo‐controlled trial
2026
·
Hisashi Makino
, Masato Kasahara
, et al.
·
Diabetes Obesity and Metabolism
·
2
Low Bacteroides abundance is related to endothelial dysfunction in type 2 diabetes
2025
·
Yoko Omura-Ohata
, Cheol Son
, et al.
·
Diabetes Research and Clinical Practice
·
2
Apolipoprotein CIII in statin-treated type 2 diabetic patients: Its implications for plaque progression and instability: The pre-specified analysis from the OPTIMAL randomized controlled trial
2025
·
Satoshi Kitahara
, Yu Kataoka
, et al.
·
Atherosclerosis
·
2
Cross-cultural adaptation, validity, and reliability of weight efficacy lifestyle questionnaire for obese Japanese individuals: An observational study
2026
·
Keiko Ishikawa
, Yoshiyuki Shimizu
, et al.
·
Journal of International Nursing Research
PDF
1835-P: Effect of Luseogliflozin on Myocardial Flow Reserve in Patients with Type 2 Diabetes Mellitus (LUCENT-J Study)
2026
·
TAMIKO TAMANAHA
, CHEOL SON
, et al.
·
Diabetes
Psychological flexibility patterns in patients with type 2 diabetes mellitus and its associations with self-care behavior and medical condition
2026
·
Taiki Shima
, Aiko Ohya
, et al.
·
BMC Psychology
Author response for "Effect of empagliflozin on urinary albumin excretion and hypoxic biomarkers in early diabetic kidney disease: A randomized double-blind, placebo-controlled trial"
2026
·
Hisashi Makino
, Masato Kasahara
, et al.
·
Publons reviews and discussion
Author response for "Effect of empagliflozin on urinary albumin excretion and hypoxic biomarkers in early diabetic kidney disease: A randomized double-blind, placebo-controlled trial"
2025
·
Hisashi Makino
, Masato Kasahara
, et al.
·
Publons reviews and discussion
Different response of plaque regression following achievement of LDL-C <1.8 mmol/L in obese and nonobese patients with diabetes and coronary artery disease: OPTIMAL sub-analysis
2025
·
Anthony Salib
, Yu Kataoka
, et al.
·
Journal of clinical lipidology
PDF
Long term effect of LDL-apheresis on patients with homozygous familial hypercholesterolemia
2012
·
Ayako Tanaka
, Hisashi Makino
, et al.
Show more works
View as search
Works count:
21
Citation count:
134
H-index:
6
I10-index:
3
Year
Topic
Type